通过微生物生物修复来进行制药废弃物管理
Kishore Srinivasan1, Raghu Chandrashekar Hariharapura1, Subrahmanyam Volety Mallikarjuna2
1Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Environmental monitoring and assessment
|March 31, 2025
概括
制药制造业产生对生态系统有害的废物. 使用微生物的生物修复为制药废物提供了具有成本效益的解决方案,尽管还在探索绿色药房方法.
科学领域:
- 环境科学 环境科学
- 微生物学 微生物学
- 绿色化学 绿色化学
背景情况:
- 制药产品 (PPs) 制造产生具有生态风险的废物.
- 药物废物的传统整治方法通常是昂贵和不切实际的.
- 环境中的制药污染物对健康构成重大风险.
研究的目的:
- 审查制药产品,它们在环境中的存在以及对健康的危害.
- 讨论微生物和药品污染物的生物修复技术.
- 探索生物修复和可持续绿色药房替代品的局限性.
主要方法:
- 关于制药污染和生物修复策略的文献综述.
- 对微生物联盟和制药废物降解技术的分析.
- 评估绿色药房对减少环境影响的方法.
主要成果:
- 使用微生物联盟的生物修复显示出作为药物废物成本有效处理的前景.
- 各种微生物和技术有效降解各种制药污染物.
- 生物修复存在局限性,需要探索可持续的替代方案.
结论:
- 生物修复是一种可行的药物废弃物管理策略,为环境带来好处.
- 可持续的绿色药房实践对于尽量减少制药污染物的生态影响至关重要.
更多相关视频
16:33Methods for Facilitating Microbial Growth on Pulp Mill Waste Streams and Characterization of the Biodegradation Potential of Cultured Microbes
Published on: December 12, 2013
9.4K
08:21Isolation and Screening from Soil Biodiversity for Fungi Involved in the Degradation of Recalcitrant Materials
Published on: May 16, 2022
4.6K
相关概念视频
00:46Bioremediation
18.1K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
18.1K
01:16Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K